Antibodies against a Leishmania infantum peroxiredoxin as a possible marker for diagnosis of visceral leishmaniasis and for monitoring the efficacy of treatment

Immunology Letters

Volumn 101, Issue 1, 2005, Pages 18-23

  Santarém, Nuno ^a,b   Tomás, Ana ^a,b   Ouaissi, Ali ^c   Tavares, Joana ^a,b   Ferreira, Nilza ^d   Manso, Arêlo ^d   Campino, Lenea ^e   Correia, José Manuel ^f   Cordeiro da Silva, Anabela ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^d Centro Hospitalar de Vila Real Peso Da Régua   (Portugal)

^e INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^f NATIONAL INSTITUTE OF HEALTH   (Portugal)

Author keywords

Cytoplasmic peroxiredoxin; Immunological marker; Leishmaniasis diagnosis

Indexed keywords

AMPHOTERICIN B; MEGLUMINE ANTIMONATE; PEROXIREDOXIN; PROTOZOON ANTIBODY; RECOMBINANT PROTEIN;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DRUG MONITORING; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOREACTIVITY; INFANT; LEISHMANIA DONOVANI; MULTICENTER STUDY; NONHUMAN; PORTUGAL; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROLOGY; TREATMENT OUTCOME; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIBODIES, PROTOZOAN; BIOLOGICAL MARKERS; CHILD; HUMANS; IMMUNOGLOBULIN G; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MONITORING, IMMUNOLOGIC; PEROXIREDOXINS;

EID: 24744460729     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2005.04.006     Document Type: Article

References (29)

1. M.E. Wilson, D.J. Innes, A.D. Sousa, and R.D. Pearson Early histopathology of experimental infection with L. donovani in hamsters J Parasitol 73 1987 55 63
2. J. Alvar, C. Canavate, B. Gutierrez-Solar, M. Jimenez, F. Laguna, and R. Lopez-Velez Leishmania and human immunodeficiency virus coinfection: the first 10 years Clin Microbiol Rev 10 1997 298 319
3. J. Kubar, J.F. Quaranta, P. Marty, A. Lelievre, Y. Le Fichoux, and J.P. Aufeuvre Transmission of L. infantum by blood donors Nat Med 3 1997 368
4. F.J. Medrano, J. Hernandez-Quero, E. Jimenez, J.A. Pineda, A. Rivero, and A. Sanchez-Quijano Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain? AIDS 6 1992 1499 1503
5. P. Desjeux, and J. Alvar Leishmania/HIV co-infections: epidemiology in Europe Ann Trop Med Parasitol 1 2003 3 15
6. P.D. Marsden Current concepts in parasitology. Leishmaniasis N Engl J Med 300 1979 350 352
7. K. Kar Serodiagnosis of leishmaniasis Crit Rev Microbiol 21 1995 123 152
8. J.J. Shaw, and A. Voller The detection of circulating antibody to kala-azar by means of immunofluorescent techniques Trans R Soc Trop Med Hyg 58 1964 349 352
9. B.C. Walton, W.H. Brooks, and I. Arjona Serodiagnosis of American Leishmaniasis by indirect fluorescent antibody test Am J Trop Med Hyg 21 1972 296 299
10. M. Hommel, W. Peters, J. Ranque, M. Quilici, and G. Lanotte The micro-ELISA technique in the serodiagnosis of visceral leishmaniasis Ann Trop Med Parasitol 72 1978 213 218
11. M.G. Pappas, R. Hajkowski, and W.T. Hockmeyer Dot enzyme-linked immunosorbent assay (Dot-ELISA): a micro technique for the rapid diagnosis of visceral leishmaniasis J Immunol Methods 64 1983 205 214
12. M. Boelaert, S. El Safi, D. Jacquet, A. de Muynck, P. van der Stuyft, and D. Le Ray Operational validation of the direct agglutination test for diagnosis of visceral leishmaniasis Am J Trop Med Hyg 60 1999 129 134
13. A.E. Harith, A.H. Kolk, P.A. Kager, J. Leeuwenburg, F.J. Faber, and R. Muigai Evaluation of a newly developed direct agglutination test (DAT) for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis: comparison with IFAT and ELISA Trans R Soc Trop Med Hyg 81 1987 603 606
14. M.A. Rab, and D.A. Evans Detection of anti-Leishmania antibodies in blood collected on filter paper by the direct agglutination test Trans R Soc Trop Med Hyg 91 1997 713 715
15. K. Zemzoumi, D. Sereno, C. Francois, E. Guilvard, J.L. Lemesre, and A. Ouaissi Leishmania major: cell type dependent distribution of a 43 kDa antigen related to silent information regulatory-2 protein family Biol Cell 90 1998 239 245
16. K. Zemzoumi, E. Guilvard, D. Sereno, A. Preto, M. Benlemlih, and A. Cordeiro-da-Silva Cloning of a Leishmania major gene encoding for na antigen with extensive homology to ribosomal protein S3a Gene 240 1999 57 65
17. H. Castro, C. Sousa, M. Santos, A. Cordeiro-da-Silva, L. Flohe, and A.M. Tomás Complementary antioxidant defense by cytoplasmic and mitochondrial peroxiredoxins in Leishmania infantum Free Radic Biol Med 33 2002 1552 1562
18. H. Castro, C. Sousa, M. Novais, M. Santos, H. Budde, and A. Cordeiro-da-Silva Two close linked of Leishmania infantum encode tryparedoxines localized to the cytosol and to the mitochondria Free Radic Biol Med Mol Biochem Parasitol 134 2004 137 147
19. A. Cordeiro-da-Silva, L. Cardoso, N. Araújo, H. Castro, A. Tomás, and M. Rodrigues Identification of antibodies to Leishmania silent information regulatory 2 SIR (SIR2) protein homologue during canine natural infections: pathological implications Immunol Lett 68 2003 155 162
20. O.H. Lowry, N.J. Rosebrough, L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 267 269
21. S. Holm A simple sequentially rejective multiple test procedure Scand J Stat 6 1998 65 70
22. G. Grimaldi, and R.B. Tesh Leishmaniases of the New World: current concepts and importance for the future research Clin Microbiol Rev 6 1993 230 250
23. M.W. Bohme, A. Evans, M.A. Miles, and E.J. Holborow Occurrence of autoantibodies to intermediate filament proteins in human visceral leishmaniasisand their induction by experimental polyclonal B-cell activation Immunology 59 1986 583 588
24. M.M. Bunn-Moreno, E.D. Madeira, K. Miller, J.A. Menezes, and A. Campos-Neto Hypergammaglobulinaemia in L. donovani infected hamsters: possibleassociation with a polyclonal activator of B cells and with suppression of T cell function Clin Exp Immunol 59 1995 427 434
25. A. Cordeiro-da-Silva, M. Borges-Coutimho, E. Guilvard, and A. Ouaissi Dual role of the Leishmania major Ribosomal protein S3a homologue in regulation of T and B cell activation Infect Immun 69 2001 6588 6596
26. R.L. Houghton, M. Petrescu, D.R. Benson, Y.A. Skeiky, A. Scalone, and R. Badaro A cloned antigen (recombinant K39) of L. chagasi diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug therapy J Infect Dis 177 1998 1339 1344
27. R. Badaro, T.C. Jones, E.M. Carvalho, D. Sampaio, S.G. Reed, and A. Barral New perspectives on a subclinical form of visceral leishmaniasis J Infect Dis 154 1986 1003 1011
28. G.M. Krautz, L.M. Galvao, J.R. Cancado, A. Guevara-Espinoza, A. Ouaissi, and A.U. Krettli Use of a 24-kD Trypanosoma cruzi recombinant protein to monitor cure of human Chagas' disease J Clin Microbiol 33 1995 2086 2090
29. A.G. Guevara, A. Taibi, J. Alava, R.H. Guderian, and A. Ouaissi Use of a recombinant Trypanosoma cruzi protein antigen to monitor cure of Chagas disease Trans R Soc Trop Med Hyg 89 1995 447 448